Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Enrique Alvarez

Concepts (306)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
46
2026
484
8.600
Why?
Multiple Sclerosis, Relapsing-Remitting
16
2026
82
3.900
Why?
Immunologic Factors
9
2026
255
3.270
Why?
Fingolimod Hydrochloride
6
2020
39
2.160
Why?
Natalizumab
5
2023
41
2.100
Why?
Multiple Sclerosis, Chronic Progressive
6
2023
28
2.010
Why?
Rituximab
7
2025
210
1.860
Why?
Immunosuppressive Agents
9
2024
847
1.260
Why?
Antibodies, Monoclonal, Humanized
6
2025
988
0.990
Why?
Agammaglobulinemia
2
2023
36
0.950
Why?
Dimethyl Fumarate
3
2020
12
0.950
Why?
Drug Substitution
2
2025
63
0.930
Why?
Oligoclonal Bands
3
2026
26
0.730
Why?
Neuromyelitis Optica
4
2020
138
0.680
Why?
Serum Sickness
1
2019
4
0.610
Why?
Magnetic Resonance Imaging
12
2026
3869
0.580
Why?
Adult
38
2026
40506
0.510
Why?
Medical Marijuana
1
2018
123
0.490
Why?
Middle Aged
37
2026
35928
0.490
Why?
Lymphocyte Depletion
3
2021
132
0.480
Why?
Antigens, CD20
3
2025
35
0.470
Why?
Antibodies, Monoclonal
5
2026
1524
0.470
Why?
Biomarkers
6
2026
4275
0.470
Why?
Pregnancy Complications
2
2018
592
0.470
Why?
Axons
2
2014
201
0.460
Why?
Humans
66
2026
144957
0.450
Why?
Marijuana Smoking
1
2018
250
0.450
Why?
Neurofilament Proteins
1
2014
80
0.420
Why?
Female
44
2026
78376
0.410
Why?
Clinical Trials as Topic
1
2018
1054
0.390
Why?
Anemia
1
2015
188
0.390
Why?
Chemokine CXCL13
1
2013
15
0.390
Why?
Recurrence
6
2024
1135
0.370
Why?
Male
40
2026
72406
0.360
Why?
Brain
9
2026
2941
0.320
Why?
Demyelinating Diseases
4
2026
84
0.320
Why?
T-Lymphocytes
3
2023
1982
0.300
Why?
Immunoglobulin G
4
2026
893
0.290
Why?
Muscle, Skeletal
6
2026
1796
0.280
Why?
Glatiramer Acetate
2
2019
18
0.270
Why?
Injections, Subcutaneous
2
2025
164
0.270
Why?
Walking
4
2023
545
0.270
Why?
Killer Cells, Natural
3
2021
469
0.270
Why?
Neuroimaging
2
2026
292
0.240
Why?
Leukoencephalopathies
1
2026
24
0.240
Why?
Fatigue
3
2026
366
0.240
Why?
B-Lymphocytes
3
2023
877
0.230
Why?
Patient Preference
2
2026
225
0.230
Why?
Neurons
4
2026
1642
0.220
Why?
Chromosomes, Human, X
1
2005
76
0.220
Why?
Treatment Outcome
10
2026
11695
0.220
Why?
Remyelination
1
2025
15
0.220
Why?
Administration, Intravenous
1
2025
170
0.220
Why?
Multigene Family
1
2005
204
0.220
Why?
Decision Making
2
2026
980
0.220
Why?
Immunoglobulin A
1
2026
214
0.220
Why?
Retrospective Studies
10
2025
17101
0.210
Why?
White Matter
1
2026
154
0.210
Why?
Isometric Contraction
1
2026
188
0.200
Why?
Central Nervous System
1
2026
281
0.200
Why?
Atrophy
2
2021
201
0.200
Why?
Mammary Neoplasms, Experimental
1
2003
70
0.200
Why?
Neuroprotection
1
2023
46
0.200
Why?
Diphosphonates
1
2003
68
0.190
Why?
Bone Resorption
1
2003
80
0.190
Why?
Alemtuzumab
1
2023
15
0.190
Why?
Nitro Compounds
1
2023
8
0.190
Why?
Myelin Sheath
1
2025
168
0.190
Why?
Disease Progression
7
2026
2852
0.190
Why?
Quality of Life
5
2026
3192
0.190
Why?
Cellular Senescence
1
2025
226
0.190
Why?
Microglia
1
2025
269
0.180
Why?
Thiazoles
1
2023
136
0.180
Why?
Double-Blind Method
6
2026
2029
0.180
Why?
Gadolinium
2
2022
84
0.180
Why?
Interoception
1
2021
3
0.180
Why?
Enzyme-Linked Immunosorbent Assay
3
2026
851
0.170
Why?
Nerve Tissue Proteins
1
2005
592
0.170
Why?
Diagnostic Self Evaluation
1
2021
24
0.170
Why?
Neuroblastoma
1
2023
174
0.170
Why?
Drug Costs
1
2023
116
0.170
Why?
Stair Climbing
1
2021
2
0.170
Why?
Inflammation
1
2013
2880
0.170
Why?
Crotonates
3
2026
7
0.170
Why?
Toluidines
3
2026
10
0.170
Why?
Hydroxybutyrates
3
2026
15
0.170
Why?
Resistance Training
1
2024
182
0.170
Why?
Young Adult
7
2026
14126
0.160
Why?
Lymphopenia
1
2020
65
0.160
Why?
Gene Expression Regulation, Developmental
1
2005
906
0.160
Why?
Interferon-gamma
1
2023
784
0.160
Why?
Hippocampus
3
2002
967
0.150
Why?
Personality
1
2021
132
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
154
0.150
Why?
Torso
1
2020
36
0.150
Why?
Cancer Vaccines
1
2021
160
0.150
Why?
Excitatory Amino Acid Antagonists
2
2002
108
0.150
Why?
Nitriles
3
2026
205
0.150
Why?
Neutropenia
1
2020
155
0.150
Why?
Transcutaneous Electric Nerve Stimulation
1
2019
23
0.150
Why?
Muscle Strength
2
2024
330
0.150
Why?
Disease Management
1
2023
647
0.150
Why?
Transforming Growth Factor beta
2
2017
479
0.150
Why?
Receptors, Glutamate
1
1999
26
0.150
Why?
Sodium Glutamate
1
1999
12
0.140
Why?
Pelvis
1
2020
124
0.140
Why?
Avoidance Learning
1
1999
65
0.140
Why?
Phosphodiesterase Inhibitors
1
2018
73
0.140
Why?
Nerve Net
1
2021
285
0.140
Why?
Muscle Spasticity
1
2018
63
0.140
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
257
0.130
Why?
Cognition
1
2026
1269
0.130
Why?
Dendritic Cells
1
2021
499
0.130
Why?
Immunotherapy, Adoptive
1
2021
337
0.130
Why?
Electric Stimulation Therapy
1
2018
63
0.130
Why?
Reaction Time
1
1999
438
0.130
Why?
Interferon beta-1a
1
2016
14
0.130
Why?
Gait
1
2020
313
0.120
Why?
T-Lymphocyte Subsets
1
2019
415
0.120
Why?
Psychomotor Performance
1
2019
328
0.120
Why?
Postural Balance
1
2019
240
0.120
Why?
Follow-Up Studies
3
2020
5417
0.120
Why?
Lymphocyte Activation
2
2019
1126
0.120
Why?
Continuous Positive Airway Pressure
1
2017
88
0.120
Why?
Transcription Factor RelA
1
2016
85
0.120
Why?
Drug Administration Schedule
1
2018
783
0.120
Why?
Patient Care Planning
1
2017
170
0.120
Why?
CD40 Antigens
1
2016
90
0.120
Why?
Mycophenolic Acid
1
2016
120
0.120
Why?
Prospective Studies
2
2025
7997
0.120
Why?
Movement
3
2023
294
0.110
Why?
Contrast Media
1
2018
488
0.110
Why?
Physicians
1
2023
940
0.110
Why?
Survival Analysis
1
2018
1385
0.110
Why?
Postpartum Period
1
2017
365
0.110
Why?
MAP Kinase Signaling System
1
2016
311
0.110
Why?
Monocytes
1
2017
538
0.100
Why?
Melanoma
1
2021
761
0.100
Why?
Proteomics
3
2026
1195
0.100
Why?
Pyridines
1
2018
605
0.100
Why?
Disability Evaluation
4
2018
310
0.100
Why?
Skin Neoplasms
1
2021
847
0.100
Why?
Patient Participation
1
2017
433
0.100
Why?
Pain
1
2018
782
0.100
Why?
Sleep Apnea, Obstructive
1
2017
300
0.090
Why?
Aged
7
2026
25947
0.090
Why?
Rats
5
2005
5614
0.090
Why?
Dopamine
2
2005
289
0.090
Why?
Adolescent
5
2026
22453
0.090
Why?
Leukoencephalopathy, Progressive Multifocal
1
2011
38
0.080
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
97
0.080
Why?
Time Factors
2
2021
7183
0.080
Why?
Antigen-Presenting Cells
1
2011
160
0.080
Why?
Membrane Proteins
1
2017
1167
0.080
Why?
Infusions, Intravenous
2
2023
423
0.080
Why?
Health Personnel
1
2017
748
0.080
Why?
Hypoxia
1
2017
1199
0.080
Why?
Leukocytes
1
2011
295
0.080
Why?
Animals
8
2025
38109
0.070
Why?
Lymphocytes
1
2011
382
0.070
Why?
Cross-Sectional Studies
4
2026
5872
0.070
Why?
Neoplasms
1
2024
2884
0.070
Why?
Pregnancy
2
2018
7191
0.070
Why?
Case-Control Studies
2
2013
3608
0.070
Why?
Spinal Cord
2
2012
382
0.070
Why?
MicroRNAs
1
2013
701
0.060
Why?
Biomechanical Phenomena
2
2021
842
0.060
Why?
Rats, Inbred F344
2
2003
268
0.060
Why?
Microinjections
3
2002
92
0.060
Why?
Incidental Findings
1
2026
80
0.060
Why?
Haplorhini
1
2005
52
0.060
Why?
Glycosylation
1
2026
172
0.060
Why?
Immunologic Memory
2
2019
366
0.060
Why?
Sequence Homology, Nucleic Acid
1
2005
157
0.060
Why?
Protein Aggregates
1
2026
86
0.060
Why?
Cohort Studies
3
2026
5965
0.060
Why?
Chemokine CCL11
1
2025
25
0.060
Why?
Immunoglobulin M
1
2026
284
0.050
Why?
Organ Specificity
1
2005
313
0.050
Why?
Pilot Projects
2
2021
1890
0.050
Why?
Cytoplasm
1
2005
269
0.050
Why?
Proteasome Endopeptidase Complex
1
2005
159
0.050
Why?
Species Specificity
1
2005
574
0.050
Why?
Risk Factors
1
2018
10792
0.050
Why?
Parathyroid Hormone-Related Protein
1
2003
25
0.050
Why?
Electric Stimulation
2
2021
276
0.050
Why?
Tyrosine 3-Monooxygenase
1
2004
71
0.050
Why?
Osteolysis
1
2003
16
0.050
Why?
Nerve Growth Factors
1
2004
78
0.050
Why?
Electromyography
1
2026
415
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2005
758
0.050
Why?
Models, Biological
1
2011
1822
0.050
Why?
Cytokines
1
2011
2065
0.050
Why?
Pluripotent Stem Cells
1
2004
84
0.050
Why?
Depression
2
2026
1559
0.050
Why?
Clinical Trials, Phase IV as Topic
1
2022
3
0.050
Why?
Oligodendroglia
1
2025
187
0.050
Why?
Mice
3
2025
18365
0.050
Why?
Aging
2
2025
1966
0.050
Why?
Kynurenic Acid
1
2002
18
0.050
Why?
Arm
1
2023
110
0.050
Why?
Intermediate Filaments
1
2022
25
0.050
Why?
Histamine
1
1982
53
0.050
Why?
Cell Nucleus
1
2005
619
0.040
Why?
Maze Learning
1
2002
104
0.040
Why?
Arthritis, Rheumatoid
1
2011
1169
0.040
Why?
Behavior, Animal
2
2002
520
0.040
Why?
Cell Division
1
2003
766
0.040
Why?
Patient Outcome Assessment
1
2023
134
0.040
Why?
Base Sequence
1
2005
2191
0.040
Why?
Regional Blood Flow
1
2024
514
0.040
Why?
MART-1 Antigen
1
2021
8
0.040
Why?
Heart
1
2005
636
0.040
Why?
Gray Matter
1
2022
92
0.040
Why?
Research Report
1
2021
87
0.040
Why?
Neoplasm Metastasis
1
2003
695
0.040
Why?
Molecular Sequence Data
1
2005
2931
0.040
Why?
Multicenter Studies as Topic
1
2022
405
0.040
Why?
Cell Survival
1
2003
1098
0.040
Why?
Receptors, N-Methyl-D-Aspartate
1
2002
228
0.040
Why?
Long-Term Potentiation
1
2002
200
0.040
Why?
Mobility Limitation
1
2020
66
0.040
Why?
Complement System Proteins
1
2023
316
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
338
0.040
Why?
Feasibility Studies
1
2024
1095
0.040
Why?
Antibodies, Viral
1
2023
672
0.040
Why?
Lymphocyte Count
1
2019
164
0.040
Why?
Maintenance Chemotherapy
1
2019
42
0.040
Why?
Indolizines
1
2018
13
0.040
Why?
Adaptation, Physiological
1
2023
570
0.040
Why?
Motor Skills
1
2019
104
0.040
Why?
Induction Chemotherapy
1
2019
87
0.040
Why?
Gene Expression Profiling
1
2005
1786
0.030
Why?
Hand
1
2019
161
0.030
Why?
Diffusion Tensor Imaging
1
2018
73
0.030
Why?
Combined Modality Therapy
1
2021
1268
0.030
Why?
Myeloid Cells
1
2019
148
0.030
Why?
Leg
1
2019
239
0.030
Why?
Homeostasis
1
2021
640
0.030
Why?
Headache
1
2018
150
0.030
Why?
Organ Size
1
2018
463
0.030
Why?
Knee Joint
1
2021
426
0.030
Why?
Macrophages
1
2025
1511
0.030
Why?
Tumor Escape
1
2017
49
0.030
Why?
Neoplasm Staging
1
2021
1465
0.030
Why?
Cytotoxicity, Immunologic
1
2017
223
0.030
Why?
Liver
1
2005
1888
0.030
Why?
Internet
1
2021
700
0.030
Why?
Memory
1
1999
296
0.030
Why?
Gastrointestinal Diseases
1
2018
216
0.030
Why?
T-Lymphocytes, Regulatory
1
2019
389
0.030
Why?
Cluster Analysis
1
2017
521
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
173
0.030
Why?
Cell Differentiation
1
2004
2050
0.030
Why?
Randomized Controlled Trials as Topic
1
2022
1721
0.030
Why?
Cell Line, Tumor
1
2003
3550
0.030
Why?
Risk
1
2017
911
0.030
Why?
Pyrazoles
1
2018
510
0.030
Why?
Apoptosis
1
2023
2430
0.030
Why?
Focus Groups
1
2017
573
0.030
Why?
Clinical Decision-Making
1
2017
359
0.030
Why?
Mice, Inbred C57BL
1
2025
5997
0.030
Why?
Drug Therapy, Combination
1
2016
1048
0.020
Why?
Incidence
1
2020
2883
0.020
Why?
Prognosis
1
2022
4293
0.020
Why?
Genetic Markers
1
2013
331
0.020
Why?
Socioeconomic Factors
1
2017
1327
0.020
Why?
Antineoplastic Agents
1
2003
2197
0.020
Why?
Patient-Centered Care
1
2017
544
0.020
Why?
Phosphorylation
1
2016
1733
0.020
Why?
Pandemics
1
2020
1695
0.020
Why?
Statistics, Nonparametric
1
2012
427
0.020
Why?
Down-Regulation
1
2013
627
0.020
Why?
Infant, Newborn
1
2023
6434
0.020
Why?
Pain Measurement
1
2012
555
0.020
Why?
Electronic Health Records
1
2017
1177
0.020
Why?
Pain Management
1
2012
405
0.020
Why?
Predictive Value of Tests
1
2013
2118
0.020
Why?
Aged, 80 and over
1
2017
8279
0.010
Why?
Severity of Illness Index
1
2012
2925
0.010
Why?
Glial Cell Line-Derived Neurotrophic Factor
1
2004
17
0.010
Why?
Cell Shape
1
2004
57
0.010
Why?
Mesencephalon
1
2004
65
0.010
Why?
Culture Media, Conditioned
1
2004
111
0.010
Why?
Stromal Cells
1
2004
125
0.010
Why?
Coculture Techniques
1
2004
246
0.010
Why?
Grooming
1
1982
9
0.010
Why?
Stem Cell Transplantation
1
2004
191
0.010
Why?
Spermine
1
2002
29
0.010
Why?
Rats, Inbred Strains
1
1982
321
0.010
Why?
Corpus Striatum
1
2004
179
0.010
Why?
Oligonucleotides, Antisense
1
2002
116
0.010
Why?
Astrocytes
1
2004
224
0.010
Why?
Excitatory Postsynaptic Potentials
1
2002
117
0.010
Why?
Catheterization
1
2002
183
0.010
Why?
Locomotion
1
1982
105
0.010
Why?
Calcium Channel Blockers
1
2002
165
0.010
Why?
United States
1
2018
15988
0.010
Why?
In Vitro Techniques
1
2002
1048
0.010
Why?
Blotting, Western
1
2002
1187
0.010
Why?
Action Potentials
1
2002
507
0.010
Why?
Parkinson Disease
1
2004
600
0.010
Why?
Gene Expression
1
2002
1490
0.010
Why?
Cell Proliferation
1
2004
2499
0.010
Why?
Cells, Cultured
1
2004
4155
0.010
Why?
Phenotype
1
2004
3164
0.010
Why?
Alvarez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)